Technologie de la santé
Sociétés Américaines engagées dans un secteur: technologie de la santé
Ces Sociétés Américaines opèrent dans le même secteur, technologie de la santé. Chacune d'entre elles comprend des statistiques clés telles que le cours de l'action, la variation quotidienne et le volume de transactions pour vous aider à prendre des décisions de trading plus éclairées. Que vous suiviez des géants du secteur tels que Eli Lilly and Company ou que vous observiez des sociétés à fort volume de transactions comme Pfizer Inc., cette liste vous offre des informations précieuses pour toute stratégie de trading. Filtrez et comparez les entreprises et restez au fait des tendances du marché en toute simplicité.
Symbole | Capitalisation boursière | Prix | Chg % | Vol | Vol Rel | P/E | BPA dil TTM | Croissance dil du BPA YoY TTM | Rendement du Dividende % TTM | Note des analystes |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 1,09 T USD | 1 152,93 USD | +0,04% | 4,55 M | 2,22 | 39,18 | 29,43 USD | +95,14% | 0,58% | Buy |
 JNJJohnson & Johnson | 650,65 B USD | 269,99 USD | −0,09% | 16,43 M | 2,95 | 31,29 | 8,63 USD | −7,72% | 1,96% | Buy |
 ABBVAbbVie, Inc. | 466,45 B USD | 263,96 USD | −0,02% | 8,18 M | 1,95 | 74,63 | 3,54 USD | +68,31% | 2,59% | Buy |
 MRKMerck & Co., Inc. | 362,35 B USD | 146,87 USD | −0,19% | 31,16 M | 3,85 | 117,39 | 1,25 USD | −80,71% | 2,29% | Buy |
 AZNAstraZeneca PLC | 257,57 B USD | 166,08 USD | −0,04% | 3,06 M | 0,92 | 25,14 | 6,61 USD | +17,00% | 0,00% | Strong Buy |
 NVSNovartis AG Sponsored ADRDR | 255,41 B USD | 140,37 USD | −0,39% | 2,25 M | 0,74 | 21,18 | 6,63 USD | −4,00% | 2,20% | Neutre |
 TMOThermo Fisher Scientific Inc. | 240,87 B USD | 651,45 USD | −1,04% | 4,58 M | 2,05 | 35,04 | 18,59 USD | +7,60% | 0,28% | Buy |
 AMGNAmgen Inc. | 208,49 B USD | 385,65 USD | +1,55% | 8,53 M | 2,85 | 23,96 | 16,10 USD | +31,70% | 2,58% | Neutre |
 NVONovo Nordisk A/S Sponsored ADR Class BDR | 191,08 B USD | 43,24 USD | +0,12% | 10,37 M | 1,13 | 10,57 | 4,09 USD | +12,75% | 2,85% | Neutre |
 GILDGilead Sciences, Inc. | 186,13 B USD | 150,11 USD | −0,52% | 16,42 M | 3,04 | — | −2,66 USD | −152,84% | 2,15% | Buy |
 ABTAbbott Laboratories | 177,55 B USD | 102,61 USD | +0,37% | 27,08 M | 3,60 | 33,17 | 3,09 USD | −61,31% | 2,42% | Buy |
 PFEPfizer Inc. | 157,65 B USD | 27,66 USD | +0,07% | 75,59 M | 2,61 | 36,63 | 0,76 USD | −59,83% | 6,22% | Neutre |
 DHRDanaher Corporation | 148,9 B USD | 211,81 USD | −0,32% | 8,84 M | 2,55 | 37,61 | 5,63 USD | +19,62% | 0,68% | Strong Buy |
 ISRGIntuitive Surgical, Inc. | 138,95 B USD | 393,33 USD | +2,55% | 4,93 M | 1,96 | 45,08 | 8,73 USD | +21,75% | 0,00% | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 128,84 B USD | 508,34 USD | −1,55% | 2,43 M | 2,84 | 29,57 | 17,19 USD | +22,86% | 0,00% | Buy |
 BMYBristol-Myers Squibb Company | 128,81 B USD | 63,06 USD | +0,35% | 36,85 M | 4,65 | 13,89 | 4,54 USD | +83,17% | 3,98% | Buy |
 MDTMedtronic Plc | 117,85 B USD | 92,13 USD | −0,69% | 15,45 M | 1,91 | 22,68 | 4,06 USD | +12,15% | 3,09% | Buy |
 SYKStryker Corporation | 105,53 B USD | 275,12 USD | −1,79% | 4,81 M | 1,33 | 28,51 | 9,65 USD | +27,71% | 1,26% | Buy |
 SNYSanofi SA Sponsored ADRDR | 101,94 B USD | 42,48 USD | −1,53% | 2,24 M | 0,96 | 21,88 | 1,94 USD | −30,91% | 4,15% | Buy |
 GSKGSK plc Sponsored ADRDR | 100,46 B USD | 50,22 USD | −1,65% | 4,71 M | 1,79 | 15,82 | 3,17 USD | +47,95% | 3,56% | Neutre |
 REGNRegeneron Pharmaceuticals, Inc. | 80,8 B USD | 784,85 USD | −0,58% | 2,47 M | 4,56 | 19,40 | 40,46 USD | +1,95% | 0,47% | Buy |
 BSXBoston Scientific Corporation | 62,81 B USD | 43,34 USD | −0,48% | 29,28 M | 1,28 | 17,57 | 2,47 USD | +46,77% | 0,00% | Buy |
 ARGXargenx SE Sponsored ADRDR | 62,57 B USD | 990,32 USD | −0,55% | 244,02 K | 1,14 | 37,74 | 26,24 USD | +33,38% | 0,00% | Strong Buy |
 MRNAModerna, Inc. | 61,5 B USD | 154,04 USD | −2,55% | 20,24 M | 1,72 | — | −7,98 USD | −6,20% | 0,00% | Neutre |
 TAKTakeda Pharmaceutical Co. Ltd. Sponsored ADRDR | 61,05 B USD | 18,91 USD | −0,73% | 2,96 M | 1,25 | — | −0,34 USD | −214,18% | 3,09% | Buy |
 NTRANatera, Inc. | 53,25 B USD | 369,39 USD | +0,84% | 3,72 M | 3,07 | — | −1,37 USD | +28,02% | 0,00% | Strong Buy |
 EWEdwards Lifesciences Corporation | 50,87 B USD | 88,26 USD | +0,01% | 4,26 M | 1,31 | 52,37 | 1,69 USD | +15,05% | 0,00% | Buy |
 BDXBecton, Dickinson and Company | 49,29 B USD | 180,94 USD | −0,24% | 6,42 M | 3,87 | 54,58 | 3,32 USD | −40,38% | 2,32% | Buy |
 TEVATeva Pharmaceutical Industries Limited | 45,42 B USD | 38,98 USD | −0,54% | 5,48 M | 1,13 | 55,40 | 0,70 USD | — | 0,00% | Strong Buy |
 AAgilent Technologies, Inc. | 44,11 B USD | 156,47 USD | +0,08% | 4,85 M | 2,48 | 30,81 | 5,08 USD | +19,11% | 0,65% | Buy |
 IQVIQVIA Holdings Inc | 43,85 B USD | 266,42 USD | −1,12% | 5,6 M | 3,85 | 33,05 | 8,06 USD | +16,77% | 0,00% | Buy |
 MDLNMedline, Inc. Class A | 41,6 B USD | 31,64 USD | −1,49% | 19,95 M | 2,96 | 37,10 | 0,85 USD | −46,21% | 0,00% | Buy |
 WATWaters Corporation | 41,42 B USD | 421,63 USD | −1,88% | 1,04 M | 1,73 | 105,28 | 4,00 USD | −63,90% | 0,00% | Buy |
 RVMDRevolution Medicines, Inc. | 40,93 B USD | 190,95 USD | −3,04% | 5,94 M | 3,90 | — | −8,81 USD | −95,67% | 0,00% | Strong Buy |
 IDXXIDEXX Laboratories, Inc. | 40,31 B USD | 511,65 USD | +1,02% | 1,12 M | 2,30 | 35,96 | 14,23 USD | +18,43% | 0,00% | Buy |
 HLNHaleon PLC Sponsored ADRDR | 40,01 B USD | 9,28 USD | −0,85% | 45,17 M | 2,57 | 19,08 | 0,49 USD | +12,39% | 2,02% | Buy |
 ONCBeOne Medicines Ltd. Sponsored ADRDR | 40,01 B USD | 350,84 USD | −0,74% | 438,38 K | 1,14 | 61,65 | 5,69 USD | — | 0,00% | Strong Buy |
 ILMNIllumina, Inc. | 36,18 B USD | 239,62 USD | −2,27% | 32,59 M | 14,19 | 44,66 | 5,37 USD | −32,04% | 0,00% | Buy |
 DXCMDexCom, Inc. | 33,72 B USD | 89,35 USD | +1,61% | 14,58 M | 3,89 | 35,27 | 2,53 USD | +77,36% | 0,00% | Strong Buy |
 RPRXRoyalty Pharma Plc Class A | 33,59 B USD | 58,41 USD | −0,88% | 7,1 M | 2,03 | 31,09 | 1,88 USD | −18,22% | 1,58% | Buy |
 ALCAlcon AG | 32,5 B USD | 65,04 USD | −0,21% | 3,46 M | 2,08 | 50,71 | 1,28 USD | −45,93% | 0,52% | Buy |
 RMDResMed Inc. | 32,46 B USD | 224,99 USD | −1,50% | 3,86 M | 3,19 | 21,56 | 10,44 USD | +9,76% | 1,09% | Buy |
 ALNYAlnylam Pharmaceuticals, Inc | 32,06 B USD | 239,56 USD | −2,42% | 2,76 M | 1,91 | 40,45 | 5,92 USD | — | 0,00% | Buy |
 BIIBBiogen Inc. | 31,84 B USD | 215,50 USD | −1,62% | 2,64 M | 3,68 | 38,16 | 5,65 USD | −45,98% | 0,00% | Buy |
 ZTSZoetis, Inc. Class A | 29,5 B USD | 71,40 USD | −2,22% | 9,88 M | 2,17 | 11,75 | 6,08 USD | +4,59% | 2,93% | Buy |
 GEHCGE Healthcare Technologies Inc. | 28,97 B USD | 64,13 USD | −0,49% | 7,63 M | 2,25 | 14,74 | 4,35 USD | −10,91% | 0,22% | Buy |
 ROIVRoivant Sciences Ltd. | 28,73 B USD | 39,77 USD | −0,53% | 32,2 M | 3,58 | — | −0,44 USD | +37,24% | 0,00% | Strong Buy |
 MTDMettler-Toledo International Inc. | 27,9 B USD | 1 392,32 USD | −1,28% | 544,54 K | 2,78 | 31,34 | 44,43 USD | +12,54% | 0,00% | Neutre |
 INSMInsmed Incorporated | 26,21 B USD | 120,00 USD | −3,21% | 3,45 M | 1,69 | — | −4,11 USD | +28,02% | 0,00% | Strong Buy |
 WSTWest Pharmaceutical Services, Inc. | 25,5 B USD | 362,31 USD | −1,17% | 1,46 M | 2,62 | 46,32 | 7,82 USD | +17,18% | 0,24% | Strong Buy |
 INCYIncyte Corporation | 25,4 B USD | 125,31 USD | −1,81% | 3,7 M | 2,79 | 15,97 | 7,85 USD | +78,38% | 0,00% | Buy |
 BNTXBioNTech SE Sponsored ADRDR | 24,13 B USD | 96,06 USD | −2,64% | 1,2 M | 1,40 | — | −7,85 USD | −390,40% | 0,00% | Buy |
 GHGuardant Health, Inc. | 24,07 B USD | 179,38 USD | −2,03% | 3,08 M | 1,90 | — | −3,50 USD | −4,60% | 0,00% | Strong Buy |
 UTHRUnited Therapeutics Corporation | 21,22 B USD | 494,63 USD | −0,53% | 1,5 M | 2,05 | 17,69 | 27,96 USD | +9,16% | 0,00% | Strong Buy |
 GMABGenmab A/S Sponsored ADRDR | 20,68 B USD | 34,74 USD | +0,59% | 2,71 M | 1,50 | 27,51 | 1,26 USD | −36,98% | 0,00% | Strong Buy |
 STESTERIS plc | 19,99 B USD | 205,04 USD | −1,44% | 1,54 M | 2,39 | 25,06 | 8,18 USD | +24,05% | 1,23% | Buy |
 VTRSViatris, Inc. | 19,47 B USD | 16,95 USD | −1,05% | 15,65 M | 2,08 | — | −0,36 USD | +87,72% | 2,83% | Buy |
 ZBHZimmer Biomet Holdings, Inc. | 18,19 B USD | 95,36 USD | +1,18% | 3,95 M | 1,90 | 23,21 | 4,11 USD | +0,06% | 1,01% | Neutre |
 RVTYRevvity, Inc. | 16,01 B USD | 143,45 USD | −2,24% | 3,32 M | 1,61 | 68,13 | 2,11 USD | −10,66% | 0,20% | Neutre |
 JAZZJazz Pharmaceuticals Public Limited Company | 15,63 B USD | 240,74 USD | −1,27% | 2,21 M | 4,02 | 16,60 | 14,50 USD | — | 0,00% | Strong Buy |
 NBIXNeurocrine Biosciences, Inc. | 14,86 B USD | 146,23 USD | −3,69% | 2,82 M | 2,91 | 21,42 | 6,83 USD | +101,48% | 0,00% | Strong Buy |
 ASNDAscendis Pharma A/S | 14,77 B USD | 236,72 USD | −0,97% | 1,56 M | 1,63 | 18,04 | 13,12 USD | — | 0,00% | Strong Buy |
 EXELExelixis, Inc. | 14,46 B USD | 58,36 USD | −0,22% | 5,24 M | 2,61 | 18,33 | 3,18 USD | +52,70% | 0,00% | Buy |
 SMMTSummit Therapeutics Inc | 14,24 B USD | 17,85 USD | +0,73% | 13,06 M | 1,93 | — | −1,12 USD | −11,10% | 0,00% | Buy |
 BBIOBridgeBio Pharma, Inc. | 13,02 B USD | 66,61 USD | −1,04% | 4,1 M | 1,65 | — | −3,57 USD | +12,83% | 0,00% | Strong Buy |
 HALOHalozyme Therapeutics, Inc. | 12,76 B USD | 112,45 USD | +2,53% | 10,18 M | 7,14 | 33,60 | 3,35 USD | −23,55% | 0,00% | Buy |
 PENPenumbra, Inc. | 12,51 B USD | 317,60 USD | −0,40% | 994,5 K | 2,94 | 77,99 | 4,07 USD | +7,97% | 0,00% | Neutre |
 BMRNBioMarin Pharmaceutical Inc. | 12,38 B USD | 63,94 USD | −1,75% | 4,46 M | 2,50 | 172,39 | 0,37 USD | −89,01% | 0,00% | Buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 12,28 B USD | 531,52 USD | −0,54% | 330,62 K | 1,59 | — | −12,88 USD | −0,28% | 0,00% | Strong Buy |
 CORTCorcept Therapeutics Incorporated. | 11,92 B USD | 110,29 USD | −3,98% | 17,23 M | 19,06 | 263,41 | 0,42 USD | −62,74% | 0,00% | Buy |
 BAXBaxter International Inc. | 11,79 B USD | 22,80 USD | −0,96% | 9,97 M | 1,70 | — | −1,93 USD | −626,14% | 0,18% | Neutre |
 SNNSmith & Nephew plc Sponsored ADRDR | 11,48 B USD | 27,56 USD | −0,79% | 1,45 M | 0,82 | 18,79 | 1,47 USD | +30,72% | 2,73% | Neutre |
 TECHBio-Techne Corporation | 11,35 B USD | 72,37 USD | −0,06% | 5,02 M | 1,79 | 62,47 | 1,16 USD | +155,44% | 0,44% | Neutre |
 ELANElanco Animal Health, Inc. | 11,2 B USD | 22,42 USD | −1,41% | 7,95 M | 1,54 | — | −0,40 USD | −146,35% | 0,00% | Strong Buy |
 TWSTTwist Bioscience Corp. | 10,99 B USD | 166,99 USD | +7,35% | 3,07 M | 1,82 | — | −2,22 USD | −53,17% | 0,00% | Buy |
 AXSMAxsome Therapeutics, Inc. | 10,88 B USD | 207,78 USD | −3,03% | 869,32 K | 1,40 | — | −3,76 USD | +25,87% | 0,00% | Strong Buy |
 COOCooper Companies, Inc. | 10,51 B USD | 55,29 USD | +2,82% | 8,8 M | 1,41 | 18,87 | 2,93 USD | +44,27% | 0,00% | Buy |
 AVTRAvantor, Inc. | 10,5 B USD | 15,52 USD | −2,14% | 14,83 M | 1,67 | — | −0,85 USD | −184,09% | 0,00% | Neutre |
 ALGNAlign Technology, Inc. | 10,49 B USD | 147,61 USD | −1,40% | 1,5 M | 1,75 | 25,61 | 5,76 USD | −2,76% | 0,00% | Buy |
 RDYDr. Reddy's Laboratories Ltd. Sponsored ADRDR | 10,19 B USD | 12,19 USD | 0,00% | 1,89 M | 0,58 | 27,39 | 0,45 USD | −44,33% | 0,53% | Neutre |
 BIOBio-Rad Laboratories, Inc. Class A | 10,11 B USD | 376,41 USD | −1,57% | 324,35 K | 1,28 | 45,60 | 8,25 USD | −29,66% | 0,00% | Neutre |
 RGENRepligen Corporation | 9,98 B USD | 176,89 USD | −0,73% | 1,36 M | 1,48 | 241,09 | 0,73 USD | — | 0,00% | Strong Buy |
 TXG10x Genomics Inc Class A | 9,98 B USD | 76,60 USD | −0,48% | 2,89 M | 1,05 | — | −0,59 USD | +16,02% | 0,00% | Buy |
 KRYSKrystal Biotech, Inc. | 9,97 B USD | 336,67 USD | −0,61% | 1 M | 4,09 | 42,19 | 7,98 USD | +62,32% | 0,00% | Strong Buy |
 GMEDGlobus Medical Inc Class A | 9,95 B USD | 74,08 USD | −0,11% | 2,9 M | 1,86 | 18,94 | 3,91 USD | +50,93% | 0,00% | Buy |
 KYMRKymera Therapeutics, Inc. | 9,79 B USD | 117,75 USD | −0,62% | 1,9 M | 3,01 | — | −3,24 USD | +6,73% | 0,00% | Strong Buy |
 PODDInsulet Corporation | 9,75 B USD | 140,60 USD | −0,67% | 2,51 M | 1,52 | 27,87 | 5,04 USD | +53,51% | 0,00% | Buy |
 GKOSGlaukos Corp | 9,66 B USD | 163,81 USD | +1,48% | 1,46 M | 1,99 | — | −3,26 USD | −96,75% | 0,00% | Strong Buy |
 CYTKCytokinetics, Incorporated | 9,56 B USD | 68,78 USD | −1,63% | 4,87 M | 2,87 | — | −7,22 USD | −41,03% | 0,00% | Strong Buy |
 ARWRArrowhead Pharmaceuticals, Inc. | 9,39 B USD | 66,48 USD | −1,86% | 4,02 M | 1,69 | — | −2,24 USD | −77,56% | 0,00% | Strong Buy |
 BRKRBruker Corporation | 9,35 B USD | 61,39 USD | −2,63% | 2,82 M | 1,20 | — | −0,70 USD | −234,26% | 0,33% | Buy |
 PTGXProtagonist Therapeutics, Inc. | 9,25 B USD | 143,00 USD | −0,49% | 1,84 M | 3,39 | 137,88 | 1,04 USD | +45,54% | 0,00% | Strong Buy |
 ABVXAbivax SA Sponsored ADRDR | 9,12 B USD | 105,04 USD | −1,82% | 876,03 K | 0,70 | — | −5,25 USD | −41,66% | 0,00% | Strong Buy |
 IBRXImmunityBio Inc | 8,99 B USD | 8,48 USD | +0,24% | 18,43 M | 1,95 | — | −0,97 USD | −96,55% | 0,00% | Strong Buy |
 QGENQIAGEN NV | 8,93 B USD | 43,33 USD | −2,37% | 1,75 M | 1,13 | 22,01 | 1,97 USD | +9,47% | 0,81% | Buy |
 TGTXTG Therapeutics, Inc. | 8,71 B USD | 56,87 USD | +0,71% | 5,17 M | 3,51 | 20,71 | 2,75 USD | +633,70% | 0,00% | Strong Buy |
 PCVXVaxcyte, Inc. | 8,65 B USD | 58,13 USD | −3,71% | 2,72 M | 2,15 | — | −7,71 USD | −83,87% | 0,00% | Strong Buy |
 CAICaris Life Sciences, Inc. | 8,47 B USD | 29,98 USD | −3,04% | 14,72 M | 3,08 | 80,53 | 0,37 USD | — | 0,00% | Buy |
 PRAXPraxis Precision Medicines, Inc. | 8,35 B USD | 298,95 USD | −3,71% | 829,85 K | 2,69 | — | −12,94 USD | −5,32% | 0,00% | Strong Buy |
 SYRESpyre Therapeutics, Inc | 7,96 B USD | 90,25 USD | −2,62% | 3,36 M | 3,18 | — | −2,18 USD | +28,51% | 0,00% | Strong Buy |